On behalf of the Congress Organising Committee, we would like to invite you  to join us at the Asia-Pacific Vaccine and Immunotherapy Congress in May 2024.

The field of immunotherapy and vaccines is attracting major interest from both academics and the biopharma industry. Asia-Pacific Vaccine and Immunotherapy Congress (APVIC) will bring together experts from wide ranging areas including immunology, clinical trials, cellular and gene therapies, vaccine manufacturing, immuno-oncology, drug development and many more.

APVIC 2024 will see Immunotherapy@Brisbane, Eradicate Cancer, Melbourne Immunotherapy Network (MIN) and Australasian Immunotherapy and Vaccine Development come together. This year’s congress will provide opportunities for Early Career Researchers to present their research and connect with world leaders in the area of Immunotherapy and Vaccine development. In addition to  clinicians and scientists, we are inviting Federal and State governments and the commercial sector to attend.

The 2024 congress will be held in Australia's garden city, Melbourne. The centre of sport, music, theatre and art, all await you. Network, engage and learn with leaders in the immunotherapy and vaccine space all while enjoying the famous coffee culture.

We hope to see you there!

Lorraine O’Reilly & Ashraful Haque
APVIC 2024 Co-Conveners

Look who is speaking at APVIC 2024

  • Sylvie Alonso

    Associate Professor & Co-Director, Infectious Diseases Translational Research Programme
    Yong Loo Lin School of Medicine, National University of Singapore

  • Amy Anderson

    Senior Research Associate
    Newcastle University

  • James Baber

    Senior Director, Asia Pacific Program Lead Pfizer Vaccine Research and Development

  • Claudine Bonder

    Head of Vascular Biology and Cell Trafficking Laboratory
    Centre for Cancer Biology, University of South Australia

  • Valerie Chew

    Principal Investigator, Translational Immunology Institute (TII)
    SingHealth-DukeNUS

  • Miles Davenport

    Program Head, Infection Analytics Program
    Kirby Institute, UNSW

  • Riccardo Dolcetti

    Head of Clinical and Translational Immunotherapy
    Peter MacCallum Cancer Centre

  • Dale Godfrey

    Professor & Laboratory Head
    University of Melbourne & Peter Doherty Institute

  • David Gottlieb

    Professor of Haemotology
    University of Sydney

  • Ian Hermans

    Professor & Programme Leader
    Malaghan Institute of Medical Research, NZ

  • Paul Hertzog

    Professor, Centre for Innate Immunity & Infectious Diseases
    Hudson Institute for Medical Research

  • Geoff Hill

    Professor of Medicine, Division of Medical Oncology
    Fred Hutchinson Cancer Center

  • Nick Huntington

    Chief Scientific Officer
    oNOo-Innate, Next Generation Cytokine Therapeutics for Cancer

  • Prasanna Jagannathan M.D.

    Assistant Professor of Medicine and of Microbiology and Immunology,
    Stanford University

  • Misty Jenkins

    NHMRC Fellow and Laboratory Head Immunology Division, WEHI

  • Grant McArthur

    Executive Director, VCCC Alliance & Lorenzo Galli Chair of Melanoma and Skin Cancers
    University of Melbourne

  • Crystal Mackall

    Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and Medicine
    Stanford University

  • Sebastian Maurer-Stroh

    Executive Director
    Bioinformatics Institute (BII)
    A*STAR Singapore

  • Vivek Naranbhai

    Associate Professor & Head of the Laboratory of Translational Immunology
    Monash University

  • Jane Oliaro

    Group Leader & Chief Scientist
    Cancer Immunology Program & Centre of Excellence in Cellular Immunotherapy
    Peter MacCallum Cancer Centre

  • Joshua Ooi

    Head, Regulatory T cell Therapies Group
    Monash University

  • Ismail Sebina

    Research Fellow
    The University of Queensland’s Frazer Institute

  • Ankur Sharma

    Senior Research Fellow
    Curtin Medical School

  • Meru Sheel

    Associate Professor & Infectious Diseases Epidemiologist & Vaccinologist
    Sydney School of Public Health & University of Sydney

  • Amit Singhal

    Senior Principal Investigator
    A*STAR Infectious Diseases Labs

  • Clare Slaney

    Senior Research Fellow
    Peter MacCallum Cancer Centre

  • Helen Thomas

    Head of Immunology and Diabetes Unit
    St. Vincent’s Institute

  • Ranjeny Thomas

    Professor of Rheumatology
    University of Queensland

  • Chenqi Xu

    Professor & Assistant Director
    Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences

  • Qi Zhang

    Research Associate Professor
    School of Medicine, Tsinghua University

Lorraine O’Reilly, Co-Chair
WEHI

Ashraful Haque, Co-Chair
University of Melbourne

Rajiv Khanna
QIMR Berghofer Medical Research Institute

Gabrielle Belz
UQ Frazer Institute

Kate Gartlan
QIMR Berghofer Medical Research Institute

Di Yu
UQ Frazer Institute

Corey Smith
QIMR Berghofer Medical Research Institute

Dr. Nicole Campbell
Hudson Institute

Organising Committee

Richard Boyd
Monash University

Lisa Ng
A*STAR Infectious Diseases Labs

Laurent Renia
Lee Kong Chan School of Medicine

Riccardo Dolcetti
Peter MacCallum Cancer Centre

Dr. Julian Vivian
St. Vincent’s Institute

Ranjeny Thomas
UQ Frazer Institute

Ian Barr
Doherty Institute

Scientific Advisory Committee

Lorraine O’Reilly, Co-Chair
WEHI

Ashraful Haque, Co-Chair
University of Melbourne

Rajiv Khanna, Co-Chair
QIMR Berghofer Medical Research Institute

Gabrielle Belz, Co-Chair
UQ Frazer Institute

Richard Boyd, Co-Chair
Monash University

Ian Barr, Co-Chair
Doherty Institute

Stay connected.

Sign up with your email address to stay in the know and ensure all of the most recent news about the 2024 congress is delivered straight to your inbox!

APIC2024 - 2nd Australian Paediatric Immunotherapy Conference is a proud Satellite event of APVIC 2024, being held at The Larwill Studio Hotel, Parkville, Melbourne. We encourage you to register to attend both conferences. More information on APIC 2024 can be accessed here.